Stock Analysts

Cullen/Frost Reports Q4 Earnings As Expected; Shares Gain

Shares of Cullen/Frost Bankers, Inc. ( CFR ) rose 2.13% to close at $62.15, after the company posted encouraging fourth-quarter 2014 results on Wednesday, before the opening bell. Driven by strong top-line growth, the company reported earnings of $1.11 per share, significantly above the prior-year quarter figure of 99 cents […]

Stock Analysts

Tractor Supply Beats on Q4 Earnings, Initiates 2015 View

Tractor Supply Company ( TSCO ) reported better-than-expected earnings results for the fourth quarter as well as for fiscal 2014. The company’s earnings per share of 81 cents for the fourth quarter were 19.1% higher than the prior-year quarter and ahead of the Zacks Consensus Estimate of 76 cents. For the full-year, earnings of $2.66 per share surged 14.7% from $2.32 per share reported in 2013 and also surpassed the Zacks Consensus Estimate of $2.61 […]

Stock Analysts

Colgate-Palmolive (CL) Beats Q4 Earnings, Shares Soar 2.9%

Colgate-Palmolive Co. ( CL ), a global dealer in consumer goods, reported fourth-quarter 2014 adjusted earnings of 76 cents per share, a penny ahead of the Zacks Consensus Estimate and up 1% year over year. Shares of Colgate soared about 2.9% in the pre-market trading following the announcement of the company’s fourth quarter results. […]

Mergers & Acquisitions

Denver Private Equity Firm, enVision Capital, Acquires Stake in Wyoming-based Technology Company, KB Enterprises

Denver Private Equity Firm, enVision Capital, Acquires Stake in Wyoming-based Technology Company, KB Enterprises PR Newswire DENVER, Jan. 29, 2015 DENVER , Jan. 29, 2015 /PRNewswire/ — enVision Capital, a mid-stage private equity firm and division of management consulting firm, enVision Business Consulting, today announces it has acquired a stake in Laramie, Wyoming -based technology firm, KB Enterprises, LLC. […]

Technicals

Celgene (CELG) Q4 Earnings In Line with Estimates, Shares Up – Tale of the Tape

Celgene Corporation ( CELG ) a leading biopharmaceutical company engaged in the discovery, development and commercialization of drugs targeting cancer and immune/inflammatory diseases. The Summit, NJ based company is well known for Revlimid and oncology products like Vidaza, Istodax, Abraxane, Pomalyst and Thalomid. However, like many of its peers, Celgene is facing generic competition for several of the important products including Vidaza […]